During the past decade, McMaster Cardio-Respiratory Research Lab conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "McMaster Cardio-Respiratory Research Lab" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "BioGaia AB" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "McMaster Cardio-Respiratory Research Lab" are "Asthma" (4 trials), "Atopic Asthma" (2 trials), "Allergic Asthma" (1 trials), "Cough" (1 trials) and "Covid19" (1 trials). Many other conditions were trialed in "McMaster Cardio-Respiratory Research Lab" in a lesser frequency.

Most popular intervention types in "McMaster Cardio-Respiratory Research Lab" are "Drug" (4 trials), "Device" (2 trials), "Dietary Supplement" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aerogen Solo" (1 trials), "Benralizumab" (1 trials), "BioGaia-DSM17938" (1 trials), "Bone Marrow Aspiration" (1 trials) and "Methacholine Chloride" (1 trials). Other intervention names were less common.

The vast majority of trials in "McMaster Cardio-Respiratory Research Lab" are 9 trials for "All" genders.

Currently, there are NaN active trials in "McMaster Cardio-Respiratory Research Lab". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in McMaster Cardio-Respiratory Research Lab, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in McMaster Cardio-Respiratory Research Lab, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".